Coronavirus | Remdesivir production expected to start in Maharashtra’s Wardha from 28th April: Nitin Gadkari
The Hindu
Genetek LifeSciences to produce 30,000 vials of remdesivir injections per day, says the Union Minister
Union minister Nitin Gadkari on Tuesday said Genetek LifeSciences will start production of remdesivir injections, used in the treatment of COVID-19, in Wardha (Maharashtra) from Wednesday. While speaking to reporters during the inauguration of a COVID-care centre in Nagpur, Mr. Gadkari said the company will produce 30,000 vials per day. Remdesivir is approved in India for restricted emergency use for the treatment of suspected or laboratory confirmed COVID-19 in adults and children hospitalised with severe disease.More Related News
One dies, eight hospitalised after inhaling HCL fumes at pharma company in Andhra Pradesh’s Anakapalli district. About 400 litres of HCL leaked from the reactor-cum-receiver tank at Unit-III of the company, which affected nine workers, says Collector. While the condition of six of them is stable, two are on ventilator support. Chief Minister Chandrababu Naidu directs authorities to provide advanced treatment to the victims. Home Minister Anitha expresses anger over repeated such incidents.